NewsRx

Search our medical news database

Drug Law Weekly

Susan Hasty, Publisher

Table of Contents . . . February 8th, 2005

Non-Subscriber - Summaries Only

Related Areas: Other Issues in Drug Law Weekly | Other Publications

Abbott Laboratories - Indiana Circuit Court denies class certification in OxyContin litigation

Beckman Coulter, Inc. - Exclusive license agreement signed for intellectual property

BioVeris Corporation - Agreements completed with Children's Hospital & Research Center at Oakland

Biophan Technologies, Inc. - Biomedical technology firm executes letter of intent to acquire MRI company

Biophan Technologies, Inc. - Company's biomedical intellectual property portfolio crosses 100-patent mark

Bruckner Group - Biotechnology drug revenues will be hard hit by strict benefit management

CorePharma, LLC - CollaGenex seeks immediate injunctive relief to enforce its patent

Drug Importation - Canadian drug import law goes into effect

Healthcare Coverage - Employers keeping retiree drug coverage even after Part D becomes available

Legal Issues - Illinois investigating prescription drug company, report says

MedPanel, Inc. - Medical market intelligence provider launches financial group

Non-Prescription Drugs - Methamphetamine bill sparks concerns for pharmacies, others

Pharmaceutical Research and Manufact. of America - Drug discount program launched in Ohio

Powell Goldstein LLP - Law firm adds partner specializing in intellectual property and biotechnology

Sanofi-aventis - Vaccine division changes its name

Abbott - NDA submitted to U.S. FDA for advanced prostate cancer drug

Abbott Laboratories - Potent disubstituted pyridazinone cyclooxgenase-2 inhibitor developed

Aegera Therapeutics, Inc. - New board members appointed at biotech firm

Altana AG - Alvesco launched in U.K.

Amarin Corporation plc - Positive data reported from phase IIa studies of Miraxion

Arena Pharmaceuticals, Inc. - Phase II study initiated for anti-obesity compound

Argenta Discovery Ltd - Drug discovery firm appoints Ian Kent as chairman

AtheroGenics, Inc. - Pharmaceutical firm prices private offering of convertible notes

Bausch & Lomb - Ophthalmology firm to license Plasmin from Bayer

Becton, Dickinson and Company - FDA clearance granted for MRSA test

BioSante Pharmaceuticals, Inc. - Enrollment completed for Phase III clinical trial for estrogen gel

BioTec-Grunderzentrum, Braunschweig - Macrophage-activating lipopeptide accelerates wound healing in diabetes

Biovail Corporation - Approvable letter granted for Tramadol ODT

Bolder BioTechnology, Inc. - U.S. NIH grant to fund development of erythropoiesis-stimulating protein

Boston University - Leptin may be involved in placental establishment in early pregnancy

Boston University - Telomere homolog oligonucleotides induce senescence in malignant fibroblasts

BrainStorm Cell Therapeutics, Inc. - Dudy Stolick named chief financial officer at biotech firm

Brigham and Women's Hospital, Boston - Obesity and weight gain increase risk for kidney stones

CHF Solutions, Inc. - $22.9M financing completed; proceeds used to complete UNLOAD trial

CHU Timone, Marseille - IV immunoglobulin used to treat HIV patient with DILS-associated myositis

CONICET, La Plata - Report provides a chart of 25 diseases and 42 plant species employed in therapy

CRC Health Group - Thomas J. Brady named chief medical officer for substance abuse facility

Cambrex Bio Science Walkersville, Inc. - Geron agrees to distribution deal for telomerase-immortalized human cell lines

CeMines, Inc. - VTAK, a new company, to focus on diagnostic and therapeutic cancer products

Center Jean Perrin, Clermont Ferrand 1 - Researchers report on molecular mechanisms in hormonorefractory prostate cancer

Centre National de la Recherche Scientifique - Self-reactive T cell receptor-reactive CD8+ T cells inhibit lymphoma growth

Children's Hospital of Philadelphia - Heparin studied, dichotomy in anticoagulant and antithrombotic effects revealed

Chinese Academy of Sciences - Capillary electrophoresis assay devised for analysis of Rhodiola compounds

Cook, Inc. - First fenestrated endograft in study of advanced treatment for AAA is implanted

Cubist Pharmaceuticals, Inc. - Company reports Q4 Cubicin revenues of $21.0M, year-end net revenue of $58.6M

Curis, Inc. - BMP-7 promotes regeneration of injured kidneys in preclinical model

CytRx Corp. - Data shows potential of arimoclomol as a therapeutic for type 2 diabetes

Decision Resources, Inc. - Advisory firm finds doctors are at odd over fixed-dose statin combinations

Devi Ahilya University - Hypoglycemia from plant extract mediated by corticosteroid inhibition

Diet & Nutrition - Congressman asks lawmakers to focus more on preventative health

Drug Addiction - Methamphetamine-related treatment admissions increase in metro area

Duke University - Small interfering RNA augments hypoxia and radiation induced tumor cell death

Duke University, Durham - Trimetrexate/denileukin diftitox depletes T cells from PBMC/UCB grafts

Duska Therapeutics, Inc. - Pennsylvania biotech announces Standard & Poor's listing

Dyax Corp. - Antibodies enter clinical trials at ImClone Systems

Edward Jenner Institute Vaccine Res. Berkshire - Kinetics and clonality of immunological memory in humans reviewed

Egg Nutrition Center - What's on your plate may help save your sight, research shows

Emory University - Antigen-independent T cells do not develop during chronic viral infection

Emory University - Generation and maintenance of immunological memory reviewed

Emory University, Atlanta - Influence of antipsychotic drugs studied, role of receptor antagonist revealed

Emory Vaccine Center - Anthrax lethal toxin causes multisystem destruction

Enzo Biochem, Inc. - Company wins $1M grant to fund clinical trial of liver disease treatment

ID Biomedical Corporation - Biotechnology company receives U.S. FDA clearance for Fluviral clinical testing

Medical Misconduct - Prosecutor alleges Arizona hospital hid evidence of alleged rapes

Ranbaxy Inc. - Pharma company files three antiretrovirals with the U.S. FDA

Raven biotechnologies, inc. - Biotech company begins enrollment of phase 1/2a trial of RAV12

Samaritan Pharmaceuticals, Inc. - Pharmaceutical company prepares for late-stage clinical trials for HIV treatment

Sepracor Inc. - Commercial availability date for eszopiclone treatment for insomnia revised

Skinvisible, Inc. - Hand sanitizer donated to help victims of the tsunami

Spectrum Pharmaceuticals, Inc. - U.S. FDA acceptance for review of ANDA for migraine headache injection announced

U.S. Food & Drug Administration - Genistein and nonylphenol increase hypothalamus volume in male rats

US Oncology, Inc. - U.S. FDA approves albumin-bound nanoparticle paclitaxel for breast cancer

Univ. of Texas SW Medical Center - Recent findings in breast implants described

deCODE genetics - Company awarded $24 million to study genetics of infectious disease and vaccines

diaDexus, Inc. - Study supports novel test measure as risk predictor of coronary events, strokes

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook